Both in Pharmaceuticals
Spruce Biosciences vs Nkarta
Over the past year SPRB returned −59.1% and NKTX returned −26.1%; their daily moves had a correlation of 0.22.
SPRB −59.1% NKTX −26.1%Growth of $1, one year, split-adjusted
| Metric | SPRB | NKTX |
|---|---|---|
| Price | $42.81 | $1.53 |
| Market cap | $123.0M | $109.6M |
| Today | −3.91% | +0.66% |
| 1 month | −5.7% | −39.5% |
| 6 months | −27.9% | −50.3% |
| Year to date | −50.9% | −17.3% |
| 1 year | −61.1% | −27.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $89.2M | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 61.1% |
| Short % of float | 22.4% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).